Nov 30 (Reuters) - The U.S. Supreme Court on Friday agreed to decide whether human genes can be patented, a hotly contested issue with broad consequences for the future of gene-based medicine.
The nation's highest court agreed to review a case over whether Myriad Genetics Inc may patent two genes linked to hereditary breast and ovarian cancer.
In a 2-1 ruling on August 16, a panel of the U.S. Federal Circuit Court of Appeals in Washington, D.C. upheld the biotechnology company's right to patent "isolated" genes that account for most inherited forms of the two cancers.
Also on HuffPost:
More:Patent Human Genes Supreme Court Patenting Human Genes Supreme Court Patent Genes Reuters Patenting Human Genes
HuffPost Lifestyle is a daily newsletter that will make you happier and healthier — one email at a time. Learn more